Cell migration inhibiting compositions and methods and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing compound doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S740000, C514S751000

Reexamination Certificate

active

07012100

ABSTRACT:
Methods for treating an individual having cancer are provided. The method may include administering a cell migration inhibitor and a chemotherapeutic agent to the individual to inhibit migration of cancer cell. Inhibiting cell migration may increase cell division. In this manner, the cell migration inhibitor and the chemotherapeutic agent in combination may have increased efficacy compared to the chemotherapeutic agent alone due to the increased cell division. The cell migration inhibitor may include any of the inhibitors described herein. For example, the cell migration inhibitor may be an organic molecule having a molecular weight of less than about 700, a monoclonal antibody, or a natural product.

REFERENCES:
patent: 4196202 (1980-04-01), Okada
patent: 4906457 (1990-03-01), Ryan
patent: 4929635 (1990-05-01), Coquelet et al.
patent: 5189212 (1993-02-01), Ruenitz
patent: 5556992 (1996-09-01), Gaboury et al.
patent: 5773460 (1998-06-01), Gaboury et al.
patent: 5856517 (1999-01-01), Huryn et al.
patent: 5877185 (1999-03-01), Kun et al.
patent: 5932515 (1999-08-01), Rourke
patent: 5985837 (1999-11-01), Ritter et al.
patent: 5998160 (1999-12-01), Berens
patent: 6030994 (2000-02-01), Huryn et al.
patent: 6054468 (2000-04-01), Geerts et al.
patent: 6310060 (2001-10-01), Barrett et al.
patent: 6359013 (2002-03-01), Reddy et al.
patent: 2001/0018422 (2001-08-01), Ritter et el.
patent: 2002/0048813 (2002-04-01), Gertler et al.
patent: 0 677 292 (1995-10-01), None
patent: 0 747 389 (1996-12-01), None
patent: 2 284 153 (1995-05-01), None
patent: 2 288 333 (1995-10-01), None
patent: 2 303 790 (1997-03-01), None
patent: 2 312 375 (1997-10-01), None
patent: 91/07166 (1991-05-01), None
patent: 93/24442 (1993-12-01), None
patent: 96/07431 (1996-03-01), None
patent: 96/29067 (1996-09-01), None
patent: 98/58639 (1998-12-01), None
patent: 99/01421 (1999-01-01), None
patent: 01/62708 (2001-08-01), None
patent: 01/85166 (2001-11-01), None
patent: 02/20462 (2002-03-01), None
Mariani et al., “Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation gens: a cDNA microarray analysis,” 2001, Journal of Neuro-Oncology, vol. 53, pp. 161-176.
He et al., “C onstruction and Preliminary Screening of a Human Phage Single-Chain Antibody Library Associated with Gastric Cancer,” Journal of Surgical Research, Feb. 2002, vol. 102, pp. 150-155.
Berens et al., “The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay,” Clin. Exp. Metastasis, 1994, vol. 12, pp. 405-415.
Krammer et al., “Melanoma Cell Adhesion to Basement Membrane Mediated by Integrin-related Complexes,” Cancer Research, Jan. 1989, vol. 49, pp. 393-402.
International Search Report, PCT/US03/17399, mailed Nov. 17, 2005.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cell migration inhibiting compositions and methods and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell migration inhibiting compositions and methods and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell migration inhibiting compositions and methods and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3541951

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.